Merck (NYSE: MRK) reported its third quarter 2024 earnings results today.
Sales grew 4% year-over-year to $16.7 billion. Excluding FX, sales growth was 7%.
GAAP net income decreased 33% to $3.15 billion, or $1.24 per share, compared to last year. Adjusted EPS fell 26% to $1.57.
For the full year of 2024, the company expects sales of $63.6-64.1 billion and adjusted EPS of $7.72-7.77.
Prior performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Infographic: How Halliburton (HAL) performed in Q1 2025
Halliburton Company (NYSE: HAL) reported its first quarter 2025 earnings results today. Total revenue was $5.4 billion compared to $5.8 billion in the same period a year ago. Net income
GE Aerospace Q1 profit jumps on 11% revenue growth; reaffirms FY25 outlook
GE Aerospace (NYSE: GE) reported a sharp increase in earnings for the first quarter of 2025, driven by an 11% year-over-year growth in revenues. The management reaffirmed its full-year 2025
Key metrics from Kimberly-Clark’s (KMB) Q1 2025 earnings results
Kimberly-Clark Corporation (NYSE: KMB) reported its first quarter 2025 earnings results today. Net sales of $4.8 billion were 6% lower than the year-ago period. Organic sales decreased 1.6%. Net
